Skip to Content
Series

Bristol Myers Squibb CEO details promising acquisitions, healthcare message to Biden administration

January 27, 2021 00:00 AM UTC
- Updated January 27, 2021 19:17 PM UTC

Giovanni Caforio cites BMS’s medicine pipeline as strong financial asset.